{"count": 161, "results": [{"_id": "35251710", "pmid": 35251710, "pmcid": "PMC8890895", "title": "A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine", "journal": "Int J Hypertens", "authors": ["Dalal J", "Sawhney JP", "Jayagopal PB", "Hazra PK", "Khan MY", "Gaurav K", "Pinto C", "Mane A", "Rao S", "Jain M"], "date": "2022-02-23T00:00:00Z", "doi": "10.1155/2022/6868143", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "6868143", "score": 50293.656, "text_hl": "Overall, the mean duration of onset of @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@pedal edema@@@ was 69 days for @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ while 51 days for @CHEMICAL_cilnidipine @CHEMICAL_MESH:C065927 @@@cilnidipine@@@ (Figure 4(c)). ", "citations": {"NLM": "Dalal J, Sawhney JP, Jayagopal PB, Hazra PK, Khan MY, Gaurav K, Pinto C, Mane A, Rao S, Jain M. A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine Int J Hypertens. 2022;2022():6868143. PMID: 35251710", "BibTeX": "@article{35251710, title={A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine}, author={Dalal J and Sawhney JP and Jayagopal PB and Hazra PK and Khan MY and Gaurav K and Pinto C and Mane A and Rao S and Jain M}, journal={Int J Hypertens}, volume={2022}, pages={6868143}}"}}, {"_id": "35188327", "pmid": 35188327, "pmcid": "PMC8925000", "title": "Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Kim DK", "Ahn JH", "Lee KH", "Kang SH", "Kim SS", "Na JO", "Park SD", "Ahn KT", "Lee JH", "Jung IH", "Seo J", "Choi WG"], "date": "2022-03-01T00:00:00Z", "doi": "10.1111/jch.14442", "meta_date_publication": "2022 Mar", "meta_volume": "24", "meta_issue": "3", "meta_pages": "350-357", "score": 50289.98, "text_hl": "Comparison between @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine@@@ has demonstrated a reduced risk of @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@peripheral edema@@@ with the use of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine@@@. ", "citations": {"NLM": "Kim DK, Ahn JH, Lee KH, Kang SH, Kim SS, Na JO, Park SD, Ahn KT, Lee JH, Jung IH, Seo J, Choi WG. Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study J Clin Hypertens (Greenwich). 2022 Mar;24(3):350-357. PMID: 35188327", "BibTeX": "@article{35188327, title={Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study}, author={Kim DK and Ahn JH and Lee KH and Kang SH and Kim SS and Na JO and Park SD and Ahn KT and Lee JH and Jung IH and Seo J and Choi WG}, journal={J Clin Hypertens (Greenwich)}, volume={24}, number={3}, pages={350-357}}"}}, {"_id": "35234349", "pmid": 35234349, "pmcid": "PMC9106091", "title": "Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Liang L", "Kung JY", "Mitchelmore B", "Cave A", "Banh HL"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/jch.14436", "meta_date_publication": "2022 May", "meta_volume": "24", "meta_issue": "5", "meta_pages": "536-554", "score": 50278.42, "text_hl": "@CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@Nifedipine@@@ plus angiotensin receptor blocker (SUCRA: 92.3%) did not mitigate @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@peripheral edema@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ plus angiotensin-converting enzyme inhibitors (SUCRA: 16%) reduced @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@peripheral edema@@@ the most. ", "citations": {"NLM": "Liang L, Kung JY, Mitchelmore B, Cave A, Banh HL. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis J Clin Hypertens (Greenwich). 2022 May;24(5):536-554. PMID: 35234349", "BibTeX": "@article{35234349, title={Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis}, author={Liang L and Kung JY and Mitchelmore B and Cave A and Banh HL}, journal={J Clin Hypertens (Greenwich)}, volume={24}, number={5}, pages={536-554}}"}}, {"_id": "37428459", "pmid": 37428459, "title": "[Swelling of the labial gingiva of the teeth].", "journal": "Ned Tijdschr Tandheelkd", "authors": ["Raaff PI", "van der Meij EH", "de Visscher JGAM"], "date": "2023-07-01T00:00:00Z", "doi": "10.5177/ntvt.2023.07/08.23028", "meta_date_publication": "2023 Jul", "meta_volume": "130", "meta_issue": "7-8", "meta_pages": "322-325", "score": 50273.668, "text_hl": "The @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@swelling@@@ was caused by the antihypertensive @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, which he used because of arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ due to a @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@. ", "citations": {"NLM": "Raaff PI, van der Meij EH, de Visscher JGAM. [Swelling of the labial gingiva of the teeth]. Ned Tijdschr Tandheelkd. 2023 Jul;130(7-8):322-325. PMID: 37428459", "BibTeX": "@article{37428459, title={[Swelling of the labial gingiva of the teeth].}, author={Raaff PI and van der Meij EH and de Visscher JGAM}, journal={Ned Tijdschr Tandheelkd}, volume={130}, number={7-8}, pages={322-325}}"}}, {"_id": "35132803", "pmid": 35132803, "pmcid": "PMC8959262", "title": "Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension", "journal": "Vet Med Sci", "authors": ["Jang HW", "Park SM", "Hwang SY", "Kang K", "Choi M", "An JH", "Chae HK", "Oh YI", "Youn HY"], "date": "2022-03-01T00:00:00Z", "doi": "10.1002/vms3.727", "meta_date_publication": "2022 Mar", "meta_volume": "8", "meta_issue": "2", "meta_pages": "445-449", "score": 50273.332, "text_hl": "In a previous veterinary study, there were two cases of @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@peripheral edema@@@ as an adverse drug event of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in which they were administered the maximum dose of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (Creevy et al.,). ", "citations": {"NLM": "Jang HW, Park SM, Hwang SY, Kang K, Choi M, An JH, Chae HK, Oh YI, Youn HY. Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension Vet Med Sci. 2022 Mar;8(2):445-449. PMID: 35132803", "BibTeX": "@article{35132803, title={Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension}, author={Jang HW and Park SM and Hwang SY and Kang K and Choi M and An JH and Chae HK and Oh YI and Youn HY}, journal={Vet Med Sci}, volume={8}, number={2}, pages={445-449}}"}}, {"_id": "40200621", "pmid": 40200621, "title": "Beyond Amlodipine-The Case for S-amlodipine as the First Choice Calcium Channel Blocker: An Expert Opinion from India.", "journal": "J Assoc Physicians India", "authors": ["Hiremath J", "Mohan JC", "Abdullakutty J", "Bansal S", "Dalal J", "Hazra PK", "Rao S", "Shah VT", "Kubba S"], "date": "2025-04-01T00:00:00Z", "doi": "10.59556/japi.73.0927", "meta_date_publication": "2025 Apr", "meta_volume": "73", "meta_issue": "4", "meta_pages": "e33-e39", "score": 50271.113, "text_hl": "@CHEMICAL_Sulfur @CHEMICAL_MESH:D013455 @@@S@@@-@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ does not cause @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@pedal edema@@@. ", "citations": {"NLM": "Hiremath J, Mohan JC, Abdullakutty J, Bansal S, Dalal J, Hazra PK, Rao S, Shah VT, Kubba S. Beyond Amlodipine-The Case for S-amlodipine as the First Choice Calcium Channel Blocker: An Expert Opinion from India. J Assoc Physicians India. 2025 Apr;73(4):e33-e39. PMID: 40200621", "BibTeX": "@article{40200621, title={Beyond Amlodipine-The Case for S-amlodipine as the First Choice Calcium Channel Blocker: An Expert Opinion from India.}, author={Hiremath J and Mohan JC and Abdullakutty J and Bansal S and Dalal J and Hazra PK and Rao S and Shah VT and Kubba S}, journal={J Assoc Physicians India}, volume={73}, number={4}, pages={e33-e39}}"}}, {"_id": "37551050", "pmid": 37551050, "pmcid": "PMC10497034", "title": "Amlodipine in the current management of hypertension", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Wang JG", "Palmer BF", "Vogel Anderson K", "Sever P"], "date": "2023-08-07T00:00:00Z", "doi": "10.1111/jch.14709", "meta_date_publication": "2023 Aug 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.105, "text_hl": "Interestingly, in this @SPECIES_9606 @@@patient@@@ population, only four of 109 @SPECIES_9606 @@@patients@@@ (3.7%) experienced @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@edema@@@ when treated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 5 mg daily, increased to 10 mg daily after 6 weeks, if needed. ", "citations": {"NLM": "Wang JG, Palmer BF, Vogel Anderson K, Sever P. Amlodipine in the current management of hypertension J Clin Hypertens (Greenwich). 2023 Aug 7;():. PMID: 37551050", "BibTeX": "@article{37551050, title={Amlodipine in the current management of hypertension}, author={Wang JG and Palmer BF and Vogel Anderson K and Sever P}, journal={J Clin Hypertens (Greenwich)}}"}}, {"_id": "36304383", "pmid": 36304383, "pmcid": "PMC9585798", "title": "Amlodipine as a Suggested Cause of Yellow Nail Syndrome: A Case Report", "journal": "Cureus", "authors": ["Al Houri H", "Al-Tarcheh H", "Zghaier O", "Salloum S", "Haj Ibrahim A", "Kouli M"], "date": "2022-09-21T00:00:00Z", "doi": "10.7759/cureus.29396", "meta_date_publication": "2022 Sep", "meta_volume": "14", "meta_issue": "9", "meta_pages": "e29396", "score": 50265.066, "text_hl": "The presumptive diagnosis was @DISEASE_Yellow_Nail_Syndrome @DISEASE_MESH:D056684 @@@YNS@@@. Assuming @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ as a cause of interstitial @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@edema@@@, it was stopped, and the symptoms improved gradually. ", "citations": {"NLM": "Al Houri H, Al-Tarcheh H, Zghaier O, Salloum S, Haj Ibrahim A, Kouli M. Amlodipine as a Suggested Cause of Yellow Nail Syndrome: A Case Report Cureus. 2022 Sep;14(9):e29396. PMID: 36304383", "BibTeX": "@article{36304383, title={Amlodipine as a Suggested Cause of Yellow Nail Syndrome: A Case Report}, author={Al Houri H and Al-Tarcheh H and Zghaier O and Salloum S and Haj Ibrahim A and Kouli M}, journal={Cureus}, volume={14}, number={9}, pages={e29396}}"}}, {"_id": "33564260", "pmid": 33564260, "pmcid": "PMC7866951", "title": "Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension", "journal": "Pharmgenomics Pers Med", "authors": ["Liang H", "Zhang X", "Ma Z", "Sun Y", "Shu C", "Zhu Y", "Zhang Y", "Hu S", "Fu X", "Liu L"], "date": "2021-02-02T00:00:00Z", "doi": "10.2147/PGPM.S291277", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "189-197", "score": 50262.49, "text_hl": "Stratified Analyses Between SNPs and Risk of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@-Induced @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@Peripheral Edema@@@", "citations": {"NLM": "Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L. Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension Pharmgenomics Pers Med. 2021;14():189-197. PMID: 33564260", "BibTeX": "@article{33564260, title={Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension}, author={Liang H and Zhang X and Ma Z and Sun Y and Shu C and Zhu Y and Zhang Y and Hu S and Fu X and Liu L}, journal={Pharmgenomics Pers Med}, volume={14}, pages={189-197}}"}}, {"_id": "35140441", "pmid": 35140441, "title": "Cilnidipine for Amlodipine Induced Pedal Edema and its Anti-hypertensive Effect in a Tertiary Care Teaching Hospital of Western Nepal.", "journal": "J Nepal Health Res Counc", "authors": ["Kafle RC", "Sapkota S", "Maskey A"], "date": "2021-12-15T00:00:00Z", "doi": "10.33314/jnhrc.v19i3.3583", "meta_date_publication": "2021 Dec 15", "meta_volume": "19", "meta_issue": "3", "meta_pages": "618-621", "score": 50262.32, "text_hl": "Up to 15% of @SPECIES_9606 @@@patients@@@ develop @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@pedal edema@@@ with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ that may lead to discontinuation. ", "citations": {"NLM": "Kafle RC, Sapkota S, Maskey A. Cilnidipine for Amlodipine Induced Pedal Edema and its Anti-hypertensive Effect in a Tertiary Care Teaching Hospital of Western Nepal. J Nepal Health Res Counc. 2021 Dec 15;19(3):618-621. PMID: 35140441", "BibTeX": "@article{35140441, title={Cilnidipine for Amlodipine Induced Pedal Edema and its Anti-hypertensive Effect in a Tertiary Care Teaching Hospital of Western Nepal.}, author={Kafle RC and Sapkota S and Maskey A}, journal={J Nepal Health Res Counc}, volume={19}, number={3}, pages={618-621}}"}}]}